Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

MHRA set up online reporting of swine flu treatment adverse reactions

By Steve Nowottny

The MHRA has set up a new online reporting system to monitor suspected adverse reactions to antiviral use as the swine flu pandemic spreads.

The Swine Flu Adverse Drug Reaction Portal, accessible at www.mhra.gov.uk/swineflu, will enable GPs to quickly report suspected adverse reactions to Tamiflu and Relenza as well as future H1N1 vaccines once they have been developed.

The portal, which will remain in operation for the duration of the pandemic, will also be open to members of the public, as with the current Yellow Card Scehme.

In a letter to healthcare professionals Dr June Raine, the MHRA's director of vigilance and risk management of medicines, said: ‘The portal has been designed to make completing a report as quick and easy as possible.'

‘I recognise that this will be an especially busy time for healthcare professionals and I appreciate you extra effort to report. Remember, every report matters.'

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say